So I think the issue we've got with this bill is that the Director-General of Health could go to a lot of trouble in terms of banning the importation and having a very narrow regime about who can import it for particular purposes. Then we think that what we've done is we've actually eliminated the risk of drug use in the workplace when all we may have done is potentially displaced that from, basically, the use of synthetic urine to other detox products, to then using friends or other colleagues to provide a sample. Yet we've then not then gone back and focused on that relationship between the employer and the employee and creating a positive environment where we can actually really focus on the particular sources of impairment that we get in the workplace. So, basically, I think what we need to be doing is stepping back and saying, "What is our broader approach to safety in the workplace?", and then focusing on those factors in addition to drug impairment, alcohol, fatigue, and working out how we work together to identify where those systems are.